Flagged for Manual Review
Round 3 merged 8 different OpenAlex profiles by name match alone (unverified)
Metrics shown are from the primary verified profile.8 name-matched profiles were discovered and excluded from these metrics.
Quoc Dung Nguyen
Published as: Quoc Nguyen
Unknown, Unknown · RMSANZ Member (AFRM Trainees) · FAFRM
Institution(s): AU
MM 1 - Metropolitan(Postcode: 2145)
Clinical Expertise (self-reported)
Research Expertise (self-reported)
Source: RMSANZ Member Survey 2025 (Chapter 3)
Click a bar to filter publications by year
The evaluation of the use of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans and Magnetic Resonance Imaging (MRI) to better target cancer sites for men with high-risk prostate cancer requiring high dose radiotherapy as a means to improve quality of life and clinical outcomes.
Conditions: High risk prostate cancer
Sponsor: The Garvan Institute of Medical Research
Funded by: The Garvan Institute of Medical Research
The impact of androgen deprivation therapy or androgen blockage therapy on the upregulation receptor activity of Gallium68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans in men with castrate resistant prostate cancer and the use of PSMA targeted therapies.
Conditions: Metastatic Prostate Cancer
Sponsor: St Vincent's Hospital, Sydney
Funded by: The Garvan Institute of Medical Research
A multicentre open-label phase IIa study with escalating dose of MS1819-SD, to investigate the efficacy and safety of a Yarrowia lipolytica lipase preparation for the compensation of exocrine pancreatic insufficiency caused by chronic pancreatitis and/or distal pancreatectomy.
Conditions: Exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP) , Exocrine pancreatic insufficiency (EPI) caused by distal pancreatectomy.
Sponsor: INC Research Australia Pty Ltd
Funded by: AzurRx
A5011757596